(Q33788458)

29 July 2017

1 reference

title

The relationship between psychosocial parameters and outcome in irritable bowel syndrome (English)

1 reference

29 July 2017

irritable bowel syndrome

1 reference

Creed F

1

1 reference

PubMed ID

10588176

29 July 2017

language of work or name

English

0 references

publication date

1 November 1999

1 reference

American Journal of Medicine

29 July 2017

1 reference

29 July 2017

107

1 reference

29 July 2017

5A

1 reference

29 July 2017

74S-80S

1 reference

Irritable bowel syndrome: Assessment of psychological disturbance and its influence on the response to fibre supplementation

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900083-2

Prediction of outcome from the self-regulatory treatment of irritable bowel syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900083-2

Prediction of outcome from cognitive-behavioral treatment of irritable bowel syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900083-2

Influence of drug treatment on the irritable bowel syndrome and its interaction with psychoneurotic morbidity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900083-2

Hypnotherapy in severe irritable bowel syndrome: further experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900083-2

Psychiatric disorder and outcome in irritable bowel syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900083-2

Functional abdominal pain, psychiatric illness, and life events

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900083-2

Irritable bowel or irritable mind? Psychological treatment is essential for some

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900083-2

Level of chronic life stress predicts clinical outcome in irritable bowel syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900083-2

How bad are the symptoms and bowel dysfunction of patients with the irritable bowel syndrome? A prospective, controlled study with emphasis on stool form

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900083-2

Outpatients with irritable bowel syndrome: a comparison of first time and chronic attenders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900083-2

Effects of desipramine on irritable bowel syndrome compared with atropine and placebo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900083-2

A Randomised Controlled Trial of Psychotherapy in Patients with Refractory Irritable Bowel Syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900083-2

Behavioural psychotherapy in the treatment of irritable bowel syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900083-2

Psychological changes associated with self-regulatory treatments of irritable bowel syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900083-2

The role of anxiety and depression in the irritable bowel syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900083-2

Psychiatric disorder and limitations in physical functioning in a sample of the Los Angeles general population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900083-2

Controlled trial of hypnotherapy in the treatment of severe refractory irritable-bowel syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900083-2

Controlled treatment trials in the irritable bowel syndrome: a critique.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900083-2

The irritable bowel syndrome: review and a graduated multicomponent treatment approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900083-2

Prognosis in the irritable bowel syndrome: a 5-year prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900083-2

Who needs a doctor for IBS?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900083-2

Psychosocial factors in the irritable bowel syndrome. A multivariate study of patients and nonpatients with irritable bowel syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900083-2

Do patients with irritable bowel syndrome in primary care really differ from outpatients with irritable bowel syndrome?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900083-2

Anamnestic and psychological features in diagnosis and prognosis of functional abdominal complaints: a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900083-2

Abnormal illness attitudes in patients with irritable bowel syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900083-2

Histories of sexual victimization in patients with irritable bowel syndrome or inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900083-2

Medical and psychiatric symptoms in female gastroenterology clinic patients with histories of sexual victimization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900083-2

Irritable bowel-type symptoms in HMO examinees. Prevalence, demographics, and clinical correlates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900083-2

Health status by gastrointestinal diagnosis and abuse history.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900083-2

How multiple types of stressors impact on health

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900083-2

Severe sexual dysfunction in women with the irritable bowel syndrome: comparison with inflammatory bowel disease and duodenal ulceration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900083-2

Low-dose trazodone for symptomatic patients with esophageal contraction abnormalities. A double-blind, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900083-2

Effect of a tricyclic antidepressant on small intestinal motility in health and diarrhea-predominant irritable bowel syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900083-2

Antidepressant-induced analgesia in chronic non-malignant pain: a meta-analysis of 39 placebo-controlled studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900083-2

Comorbidity of gastrointestinal complaints, depression, and anxiety in the Epidemiologic Catchment Area (ECA) Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900083-2

Psychological factors in irritable bowel syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900083-2

Prevalence of psychiatric disorders in patients with irritable bowel syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900083-2

Predictors of health care seeking for irritable bowel syndrome: a population based study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900083-2

A controlled trial of psychological treatment for the irritable bowel syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900083-2

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9343(99)00083-2

1 reference

29 July 2017

1 reference

PubMed ID

10588176